Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of monkeypox cases
3.2.1.2 Increasing awareness among the population
3.2.1.3 Advancements in diagnostic research
3.2.1.4 Rising government funding and initiatives
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of testing
3.2.2.2 Stringent regulatory challenges
3.3 Technological landscape
3.4 Regulatory landscape
3.5 Porter's analysis
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Technology, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Polymerase chain reaction (PCR)
5.3 Lateral flow assay (LFA)
5.4 Other technologies
Chapter 6 Market Estimates and Forecast, By Mode, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Laboratory testing
6.3 Point of care testing
Chapter 7 Market Estimates and Forecast, By End-use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals and clinics
7.3 Diagnostic laboratories
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Netherlands
8.3.7 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Aegis Sciences Corporation
9.3 Applied DNA Sciences, Inc.
9.4 Becton, Dickinson and Company
9.5 BioGX
9.6 bioMérieux SA
9.7 Bio-Rad Laboratories, Inc.
9.8 CerTest Biotec
9.9 Creative Biogene
9.10 Danaher Corporation
9.11 Flow Health
9.12 Laboratory Corporation of America Holdings
9.13 Mayo Clinic Laboratories
9.14 Quest Diagnostics, Inc.
9.15 Thermo Fisher Scientific Inc.
